{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T05:07:05Z","timestamp":1788671225523,"version":"build-2803163510"},"reference-count":41,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T00:00:00Z","timestamp":1617840000000},"content-version":"unspecified","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2021,3,23]]},"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the prevalence of infections, prevalence of hospitalisation due to infections, the vaccination status and perceived screening of infections prior to the start of biologic disease modifying antirheumatic drugs (bDMARDs) of a patient cohort with chronic inflammatory rheumatic diseases (CIRD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Consecutive CIRD patients reporting to our specialised centre were prospectively included (n=975) in this cross-sectional study. Data on comorbidities including infections, treatment, vaccination status, screening for latent tuberculosis infection (LTBI) and hepatitis B (HepB) were collected. Antibodies against measles and HepB were measured by ELISA. The vaccination status was assessed by a predefined vaccination score (0\u201326) categorising patients into four immunisation states: low (0\u20136), moderate (7\u201313), good (14\u201320), high (21\u201326).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>All patients on bDMARDs (n=499) were screened for LTBI, and 469 for HepB (94%). All LTBI patients (n=16) received isoniazid (3.2%) and 16 chronic HepB patients received lamivudine (3.4%). Protective measles specific IgG-antibodies were found in 901 patients (92.4%). Although 629 patients were educated about vaccination strategies (64.5%), only 540 showed a vaccination card (55.4%). Only 49% of patients had undergone pneumococcal vaccination and less than 30% were protected against HepB and influenza, while 7.6% have not protective antibody titres against measles. No patient met the German national vaccination recommendations requiring a complete documentation of vaccines. The mean vaccination score was 13.3\u00b14.2 with 5.7% of patients having a low, 43.9% a moderate, 47.0% a good and 3.3% a high score.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The majority of CIRD patients are n0t sufficiently vaccinated against pneumococci, HepB, influenza and measles. Although CIRD patients and general practitioners regularly receive professional information about the need of vaccination, vaccination rates were low to moderate. Interdisciplinary quality projects should be planned to change that inacceptable result.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/rmdopen-2020-001499","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T12:52:45Z","timestamp":1617886365000},"page":"e001499","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":21,"title":["Are patients with rheumatic diseases on immunosuppressive therapies protected against preventable infections? A cross-sectional cohort study"],"prefix":"10.1136","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5668-4497","authenticated-orcid":false,"given":"Uta","family":"Kiltz","sequence":"first","affiliation":[{"name":"Rheumatology, Rheumazentrum Ruhrgebiet, Herne, Germany"},{"name":"Ruhr Universit\u00e4t Bochum, Bochum, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aylin","family":"Celik","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Klinikum Westfalen GmbH, Dortmund, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Styliani","family":"Tsiami","sequence":"additional","affiliation":[{"name":"Rheumatology, Rheumazentrum Ruhrgebiet, Herne, Germany"},{"name":"Ruhr Universit\u00e4t Bochum, Bochum, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjoern","family":"Buehring","sequence":"additional","affiliation":[{"name":"Rheumatology, Rheumazentrum Ruhrgebiet, Herne, Germany"},{"name":"Ruhr Universit\u00e4t Bochum, Bochum, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9475-9362","authenticated-orcid":false,"given":"Xenofon","family":"Baraliakos","sequence":"additional","affiliation":[{"name":"Ruhr Universit\u00e4t Bochum, Bochum, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana","family":"Andreica","sequence":"additional","affiliation":[{"name":"Rheumatology, Rheumazentrum Ruhrgebiet, Herne, Germany"},{"name":"Ruhr Universit\u00e4t Bochum, Bochum, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kiefer","sequence":"additional","affiliation":[{"name":"Rheumatology, Rheumazentrum Ruhrgebiet, Herne, Germany"},{"name":"Ruhr Universit\u00e4t Bochum, Bochum, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juergen","family":"Braun","sequence":"additional","affiliation":[{"name":"Rheumatology, Rheumazentrum Ruhrgebiet, Herne, Germany"},{"name":"Ruhr Universit\u00e4t Bochum, Bochum, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,4,8]]},"reference":[{"key":"2025090312395213000_7.1.e001499.1","doi-asserted-by":"publisher","DOI":"10.1002\/art.10524"},{"key":"2025090312395213000_7.1.e001499.2","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/rheumatology\/kex469","article-title":"Recurrent serious infections in patients with rheumatoid arthritis-results from the British Society for rheumatology biologics register","volume":"57","author":"Subesinghe","year":"2018","journal-title":"Rheumatology"},{"key":"2025090312395213000_7.1.e001499.3","doi-asserted-by":"publisher","DOI":"10.1136\/ard.53.4.224"},{"key":"2025090312395213000_7.1.e001499.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61704-9"},{"key":"2025090312395213000_7.1.e001499.5","doi-asserted-by":"publisher","DOI":"10.1002\/art.21386"},{"key":"2025090312395213000_7.1.e001499.6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.10357"},{"key":"2025090312395213000_7.1.e001499.7","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215882"},{"key":"2025090312395213000_7.1.e001499.8","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X20912646","article-title":"Reactivation of hepatitis B virus infection in rheumatic diseases: risk and management considerations","volume":"12","author":"Koutsianas","year":"2020","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"2025090312395213000_7.1.e001499.9","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2019-001041"},{"key":"2025090312395213000_7.1.e001499.10","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.137216"},{"key":"2025090312395213000_7.1.e001499.11","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.26120","article-title":"Epidemiological evidence for association between higher influenza vaccine uptake in the elderly and lower COVID-19 deaths in Italy","volume":"93","author":"Mar\u00edn-Hern\u00e1ndez","year":"2021","journal-title":"J Med Virol"},{"key":"2025090312395213000_7.1.e001499.12","unstructured":"WHO . Seasonal inlfuenza, data and statistics. Available: http:\/\/www.euro.who.int\/en\/health-topics\/communicable-diseases\/influenza\/data-and-statistics2020"},{"key":"2025090312395213000_7.1.e001499.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.04.063"},{"key":"2025090312395213000_7.1.e001499.14","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-13-158"},{"key":"2025090312395213000_7.1.e001499.15","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.13.1393"},{"key":"2025090312395213000_7.1.e001499.16","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/11.4.586"},{"key":"2025090312395213000_7.1.e001499.17","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofu024"},{"key":"2025090312395213000_7.1.e001499.18","unstructured":"Centers for Disease Control and Prevention . Pneumococcal disease: surveillance and reporting; 2020."},{"key":"2025090312395213000_7.1.e001499.19","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/jvh.12302","article-title":"Low prevalence of hepatitis B virus infection in patients with autoimmune diseases in a Chinese patient population","volume":"21","author":"Sui","year":"2014","journal-title":"J Viral Hepat"},{"key":"2025090312395213000_7.1.e001499.20","first-page":"566","article-title":"Hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologics treatment","volume":"215","author":"Chen","year":"2017","journal-title":"J Infect Dis"},{"key":"2025090312395213000_7.1.e001499.21","doi-asserted-by":"publisher","DOI":"10.1177\/2051013615599151"},{"key":"2025090312395213000_7.1.e001499.22","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-016-1898-z","article-title":"Increasing incidence associated with herpes zoster infection in British Columbia, Canada","volume":"16","author":"Marra","year":"2016","journal-title":"BMC Infect Dis"},{"key":"2025090312395213000_7.1.e001499.23","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(03)00857-0"},{"key":"2025090312395213000_7.1.e001499.24","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.puhe.2018.10.015","article-title":"Systematic review of the evidence on the epidemiology of herpes zoster: incidence in\u00a0the\u00a0general population and specific subpopulations\u00a0in Spain","volume":"167","author":"Mareque","year":"2019","journal-title":"Public Health"},{"key":"2025090312395213000_7.1.e001499.25","first-page":"333","article-title":"Recommendations of the Standing Vaccination Commission (STIKO) at the Robert Koch Institute 2017\/2018]","volume":"34","year":"2017","journal-title":"Epid Bull"},{"key":"2025090312395213000_7.1.e001499.26","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/s00103-019-02905-1","article-title":"Impfen bei Immundefizienz : Anwendungshinweise zu den von der St\u00e4ndigen Impfkommission empfohlenen Impfungen. (IV) Impfen bei Autoimmunkrankheiten, bei anderen chronisch-entz\u00fcndlichen Erkrankungen und unter immunmodulatorischer Therapie","volume":"62","author":"Wagner","year":"2019","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"2025090312395213000_7.1.e001499.27","first-page":"723","article-title":"Measles Status-Barriers to vaccination and strategies for overcoming them","volume":"115","author":"Storr","year":"2018","journal-title":"Dtsch Arztebl Int"},{"key":"2025090312395213000_7.1.e001499.28","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.1353"},{"key":"2025090312395213000_7.1.e001499.29","unstructured":"WHO . Ten threats to global health in 2019. Available: https:\/\/www.who.int\/news-room\/spotlight\/ten-threats-to-global-health-in-20192019"},{"key":"2025090312395213000_7.1.e001499.30","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2019-001035"},{"key":"2025090312395213000_7.1.e001499.31","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203341"},{"key":"2025090312395213000_7.1.e001499.32","unstructured":"Kiltz U , Celik A , Tsiami S . [How well are patients with chronic inflammatory rheumatic diseases protected against measles?]. Z Rheumatol 2020."},{"key":"2025090312395213000_7.1.e001499.33","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1214673"},{"key":"2025090312395213000_7.1.e001499.34","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209233"},{"key":"2025090312395213000_7.1.e001499.35","article-title":"Comment on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry' by Gianfrancesco M et al","author":"Andreica","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2025090312395213000_7.1.e001499.36","article-title":"[Practical problems by implementation of vaccination recommendations]","volume":"71","author":"Fendler","year":"2012","journal-title":"Z Rheumatol"},{"key":"2025090312395213000_7.1.e001499.37","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-011-1808-z"},{"key":"2025090312395213000_7.1.e001499.38","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.vaccine.2015.01.065","article-title":"Low rate of influenza and pneumococcal vaccine coverage in rheumatoid arthritis: data from the International COMORA cohort","volume":"33","author":"Hmamouchi","year":"2015","journal-title":"Vaccine"},{"key":"2025090312395213000_7.1.e001499.39","first-page":"385","article-title":"Scientific Justification for updating the recommendations for the vaccination against pneumococcus for risk groups","volume":"37","year":"2016","journal-title":"Epid Bull"},{"key":"2025090312395213000_7.1.e001499.40","first-page":"393","article-title":"Update of the meningococcal vaccine recommendation: use of the meningococcal B vaccine in persons at increased risk of meningococcal disease","volume":"37","year":"2015","journal-title":"Epid Bull"},{"key":"2025090312395213000_7.1.e001499.41","doi-asserted-by":"crossref","unstructured":"Debisarun PA , Struycken P , Dom\u00ednguez-Andr\u00e9s J . The effect of influenza vaccination on trained immunity: impact on 2 COVID-19. medRxiv preprint 2020.","DOI":"10.1101\/2020.10.14.20212498"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2020-001499","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T19:40:00Z","timestamp":1756928400000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2020-001499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,4,8]]},"published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1136\/rmdopen-2020-001499"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2020-001499","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}